Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis

Inge T.A. Peters; Claudia Marchetti; Antonella De Palma; Diana Giannarelli; Antonella Carcagnì; Giovanni Scambia; Anna Fagotti

doi:10.1016/j.ejca.2023.03.035

Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis

Inge T.A. Peters
, Claudia Marchetti
, Antonella De Palma
, Diana Giannarelli
, Antonella Carcagnì
, Giovanni Scambia
, Anna Fagotti^*

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

Lingua originale	Inglese
pagine (da-a)	77-86
Numero di pagine	10
Rivista	European Journal of Cancer
Volume	187
DOI	https://doi.org/10.1016/j.ejca.2023.03.035
Stato di pubblicazione	Pubblicato - 2023

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

Cytoreductive surgery
Epithelial ovarian cancer
PARP inhibitors
Postoperative residual disease
Progression-free survival

Accesso al documento

10.1016/j.ejca.2023.03.035

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Peters, I. T. A., Marchetti, C., De Palma, A., Giannarelli, D., Carcagnì, A., Scambia, G., & Fagotti, A. (2023). Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis. European Journal of Cancer, 187, 77-86. https://doi.org/10.1016/j.ejca.2023.03.035

@article{eadc791d873744ddb6cbdd7606e5f4f8,

title = "Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era{\textemdash}Is it time for a new paradigm shift? A systematic review and meta-analysis",

keywords = "Cytoreductive surgery, Epithelial ovarian cancer, PARP inhibitors, Postoperative residual disease, Progression-free survival, Cytoreductive surgery, Epithelial ovarian cancer, PARP inhibitors, Postoperative residual disease, Progression-free survival",

author = "Peters, \{Inge T.A.\} and Claudia Marchetti and \{De Palma\}, Antonella and Diana Giannarelli and Antonella Carcagn{\`i} and Giovanni Scambia and Anna Fagotti",

year = "2023",

doi = "10.1016/j.ejca.2023.03.035",

language = "English",

volume = "187",

pages = "77--86",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

Peters, ITA, Marchetti, C, De Palma, A, Giannarelli, D, Carcagnì, A, Scambia, G & Fagotti, A 2023, 'Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis', European Journal of Cancer, vol. 187, pagg. 77-86. https://doi.org/10.1016/j.ejca.2023.03.035

Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis. / Peters, Inge T.A.; Marchetti, Claudia; De Palma, Antonella et al.
In: European Journal of Cancer, Vol. 187, 2023, pag. 77-86.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis

AU - Peters, Inge T.A.

AU - Marchetti, Claudia

AU - De Palma, Antonella

AU - Giannarelli, Diana

AU - Carcagnì, Antonella

AU - Scambia, Giovanni

AU - Fagotti, Anna

PY - 2023

Y1 - 2023

KW - Cytoreductive surgery

KW - Epithelial ovarian cancer

KW - PARP inhibitors

KW - Postoperative residual disease

KW - Progression-free survival

KW - Cytoreductive surgery

KW - Epithelial ovarian cancer

KW - PARP inhibitors

KW - Postoperative residual disease

KW - Progression-free survival

UR - http://hdl.handle.net/10807/235570

U2 - 10.1016/j.ejca.2023.03.035

DO - 10.1016/j.ejca.2023.03.035

M3 - Article

SN - 0959-8049

VL - 187

SP - 77

EP - 86

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -